Cargando…

Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review

RATIONALE: One of the most distinctive features of epithelial ovarian cancer is tendency to disseminate into peritoneal cavity to form peritoneal carcinomatosis, indicating advanced disease with poor prognosis. PATIENT CONCERNS: A fifty-year-old patient had a chief complaint of an abdominal distensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jue, Mei, Liejun, Wang, Fubing, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717790/
https://www.ncbi.nlm.nih.gov/pubmed/33285729
http://dx.doi.org/10.1097/MD.0000000000023404
_version_ 1783619372114247680
author Zhang, Jue
Mei, Liejun
Wang, Fubing
Li, Yan
author_facet Zhang, Jue
Mei, Liejun
Wang, Fubing
Li, Yan
author_sort Zhang, Jue
collection PubMed
description RATIONALE: One of the most distinctive features of epithelial ovarian cancer is tendency to disseminate into peritoneal cavity to form peritoneal carcinomatosis, indicating advanced disease with poor prognosis. PATIENT CONCERNS: A fifty-year-old patient had a chief complaint of an abdominal distension lasting 1 month. DIAGNOSES: The patient was diagnosed with advanced epithelial ovarian cancer with peritoneal carcinomatosis by computed tomography scan, tumor markers, endoscopy examination, and pathology. INTERVENTIONS: The patient was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy followed by 8 cycles of systemic chemotherapy. OUTCOMES: Till March 9, 2020, the patient has disease-free survival over 10 years. LESSONS: The application of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy combined with systematic chemotherapy may improve survival dramatically for the patients with epithelial ovarian cancer and peritoneal carcinomatosis and should be considered as an option of a relatively new regime.
format Online
Article
Text
id pubmed-7717790
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77177902020-12-07 Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review Zhang, Jue Mei, Liejun Wang, Fubing Li, Yan Medicine (Baltimore) 5700 RATIONALE: One of the most distinctive features of epithelial ovarian cancer is tendency to disseminate into peritoneal cavity to form peritoneal carcinomatosis, indicating advanced disease with poor prognosis. PATIENT CONCERNS: A fifty-year-old patient had a chief complaint of an abdominal distension lasting 1 month. DIAGNOSES: The patient was diagnosed with advanced epithelial ovarian cancer with peritoneal carcinomatosis by computed tomography scan, tumor markers, endoscopy examination, and pathology. INTERVENTIONS: The patient was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy followed by 8 cycles of systemic chemotherapy. OUTCOMES: Till March 9, 2020, the patient has disease-free survival over 10 years. LESSONS: The application of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy combined with systematic chemotherapy may improve survival dramatically for the patients with epithelial ovarian cancer and peritoneal carcinomatosis and should be considered as an option of a relatively new regime. Lippincott Williams & Wilkins 2020-12-04 /pmc/articles/PMC7717790/ /pubmed/33285729 http://dx.doi.org/10.1097/MD.0000000000023404 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5700
Zhang, Jue
Mei, Liejun
Wang, Fubing
Li, Yan
Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review
title Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review
title_full Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review
title_fullStr Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review
title_full_unstemmed Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review
title_short Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review
title_sort ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a case report and literature review
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717790/
https://www.ncbi.nlm.nih.gov/pubmed/33285729
http://dx.doi.org/10.1097/MD.0000000000023404
work_keys_str_mv AT zhangjue tenyearsdiseasefreesurvivalofadvancedepithelialovariancancertreatedbycytoreductivesurgeryplushyperthermicintraperitonealchemotherapyacasereportandliteraturereview
AT meiliejun tenyearsdiseasefreesurvivalofadvancedepithelialovariancancertreatedbycytoreductivesurgeryplushyperthermicintraperitonealchemotherapyacasereportandliteraturereview
AT wangfubing tenyearsdiseasefreesurvivalofadvancedepithelialovariancancertreatedbycytoreductivesurgeryplushyperthermicintraperitonealchemotherapyacasereportandliteraturereview
AT liyan tenyearsdiseasefreesurvivalofadvancedepithelialovariancancertreatedbycytoreductivesurgeryplushyperthermicintraperitonealchemotherapyacasereportandliteraturereview